2024年5月15日 · One Japanese encephalitis vaccine (called IXIARO) is available in the United States. Japanese encephalitis vaccine is approved for use in children aged 2 months and …

IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older.

What is Ixiaro vaccine? Ixiaro vaccine is used to help prevent Japanese encephalitis in adults and adolescents who are at least 17 years old. Japanese encephalitis is a serious disease caused …

2019年7月11日 · IXIARO®, or JESPECT® in Australia and New Zealand, is an inactivated Japanese encephalitis vaccine and is the only Japanese encephalitis vaccine currently …

2024年5月15日 · One inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (called IXIARO and manufactured by Valneva) is available in the United States. This vaccine …

Ixiaro is a vaccine that helps protect adults and children aged 2 months and older against Japanese encephalitis, a disease that causes inflammation of the brain. Japanese encephalitis …

IXIARO is a vaccine for use in individuals 2 months of age and older to help protect against Japanese encephalitis (JE). You cannot get the disease from IXIARO. You will need 2 doses …

Ixiaro is a vaccine that helps protect adults and children aged 2 months and older against Japanese encephalitis, a disease that causes inflammation of the brain. Japanese encephalitis …

Help protect them from Japanese encephalitis (JE) with IXIARO.1. What is JE? JE is a potentially fatal mosquito-borne disease, for which no treatment is available.2–5.

The mosquito-borne Japanese encephalitis virus (JEV) is a major threat to human health in Asia. An estimated 50,000 cases occur in the region, accounting for at least 10,000 deaths and …